{"disease":{"id":"blepharospasm","name":"Blepharospasm","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"onabotulinumtoxina","indication_name":"Blepharospasm","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Botox","generic_name":"ONABOTULINUMTOXINA","company_name":"Allergan","drug_phase":"marketed","molecular_target":"SNAP-25","drug_class":"Acetylcholine Release Inhibitor [EPC]","quality_score":60,"revenue":"5300","mechanism":"BOTOX blocks neuromuscular transmission by inhibiting acetylcholine release through cleavage of SNAP-25."},{"drug_id":"incobotulinumtoxina","indication_name":"Blepharospasm in adults","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xeomin","generic_name":"INCOBOTULINUMTOXINA","company_name":"Merz Pharms","drug_phase":"marketed","molecular_target":"","drug_class":"Acetylcholine Release Inhibitor [EPC]","quality_score":55,"revenue":null,"mechanism":"Xeomin works by blocking the release of a chemical messenger called acetylcholine, which signals muscles to contract."},{"drug_id":"incobotulinumtoxina","indication_name":"Blepharospasm","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xeomin","generic_name":"INCOBOTULINUMTOXINA","company_name":"Merz Pharms","drug_phase":"marketed","molecular_target":"","drug_class":"Acetylcholine Release Inhibitor [EPC]","quality_score":55,"revenue":null,"mechanism":"Xeomin works by blocking the release of a chemical messenger called acetylcholine, which signals muscles to contract."}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03042962","title":"Brain Networks in Dystonia","phase":"","overall_status":"RECRUITING","enrollment_count":141,"lead_sponsor_name":"Massachusetts Eye and Ear Infirmary","has_results":false},{"nct_id":"NCT03216473","title":"Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Essential Blepharospasm","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"Medy-Tox","has_results":false},{"nct_id":"NCT05103202","title":"Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin","phase":"","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"University of Texas Southwestern Medical Center","has_results":false},{"nct_id":"NCT03508882","title":"Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid Spasm","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT05618470","title":"Wumeiwan Jiawei Fang Use in Patients With Blepharospasm","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"China Academy of Chinese Medical Sciences","has_results":false},{"nct_id":"NCT00500799","title":"Brain Changes in Blepharospasm","phase":"","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","has_results":false},{"nct_id":"NCT03269123","title":"A Mechanical Device for Blepharospasm","phase":"NA","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"Oxford University Hospitals NHS Trust","has_results":false},{"nct_id":"NCT04939909","title":"Botulinum Toxin Relieves Anxiety, Depression and Sleep Disorderes in Patients With Blepharospasm","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT03938363","title":"Analysis of Gait Before and After Botulinum Toxin Treatment in Patients With Focal Dystonia","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"University Hospital, Grenoble","has_results":false},{"nct_id":"NCT00411255","title":"Brain Stimulation to Treat Blepharospasm or Meige Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","has_results":false},{"nct_id":"NCT07489430","title":"DaxibotulinumtoxinA for Blepharospasm","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT03263000","title":"Photic Blink Reflex in People With Blepharospasm and Increased Blinking","phase":"","overall_status":"TERMINATED","enrollment_count":17,"lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","has_results":false},{"nct_id":"NCT05027997","title":"Exploratory Study of Dipraglurant (ADX48621) for the Treatment of Patients With Blepharospasm","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Addex Pharma S.A.","has_results":false},{"nct_id":"NCT03903341","title":"The Role of the Upper Colliculus in the Idiopathic Blepharospasm","phase":"NA","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"University Hospital, Grenoble","has_results":false},{"nct_id":"NCT04423341","title":"Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Silkiss Eye Surgery","has_results":false}],"total":15},"guidelines":[],"source":"Drug Landscape verified database"}